La Jolla Interdisciplinary Neuroscience Center Cores - Stem Cell Core BU
拉荷亚跨学科神经科学中心核心 - 干细胞核心事业部
基本信息
- 批准号:7925710
- 负责人:
- 金额:$ 6.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-01 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAnimalsApplications GrantsAreaAstrocytesBehaviorBioinformaticsBiological AssayBiologyBrainCaliforniaCannulationsCatheterizationCell LineCell TherapyCellsCellular biologyCharacteristicsClinicalClone CellsCluster AnalysisCollaborationsCommunicationCommunitiesComplexComputer softwareConsultationsCore FacilityCryopreservationCustomDataData AnalysesDatabasesDerivation procedureDetectionDevelopmentDifferentiation AntigensES Cell LineEmbryoEnsureEnvironmentEquipmentEthicsEvaluationEventExperimental DesignsFacultyFlow CytometryFosteringFundingFutureGene DuplicationGene ExpressionGenerationsGenesGenomeGoalsGrantGuidelinesHumanHuman ResourcesImageImage AnalysisImmunohistochemistryIn VitroInjection of therapeutic agentInstitutesInternationalIntravenousKaryotype determination procedureKnowledgeLaboratoriesLeadLinkManuscriptsMeasuresMedical ResearchMentorsMethodsMicroarray AnalysisMicroscopyMotor NeuronsMusMuscle FibersNeuronsNeurosciencesNewborn InfantNorthern BlottingOutcomeOutputPathway AnalysisPlayPopulationPreparationProceduresProteinsProteomeProteomicsProtocols documentationPublishingQuality ControlRNARattusRegenerative MedicineReporterReportingResearchResearch PersonnelResearch Project GrantsResourcesReverse Transcriptase Polymerase Chain ReactionRodentRoleSNP genotypingSamplingSavingsScanningScientistSenile PlaquesServicesSorting - Cell MovementSpinal CordStagingStandardizationStem Cell ResearchStem cell transplantStem cellsSupervisionTechniquesTechnologyTimeTrainingTraining SupportTransplantationUltrasonographyUnited States National Institutes of HealthWorkWritingadult stem cellcell typeclinical applicationcostdesignembryonic stem cellexperiencefetalgene therapygenetic manipulationgenome-widehuman embryonic stem cellhuman embryonic stem cell lineimprovedin utero transplantationinsightinterdisciplinary collaborationinterestmeetingsmembermonolayernerve stem cellnervous system disorderneurogenesisneuron developmentnovelnovel strategiespromoterprotein expressionresearch facilityresearch studyself-renewalskillsstemstem cell differentiationtooltransgenic model of alzheimer diseaseuser-friendly
项目摘要
STEM CELL CORE
1. MAIN OBJECTIVES AND NEW DIRECTIONS
The Stem Cell Core will be a new facility. Currently, there is no unified Stem Cell Core Facility to link
neuroscientists on the La Jolla Torrey Pines Mesa. Therefore, this Stem Cell facility will constitute a
new Core to foster stem cell projects and collaborations among neuroscientists in the San Diego area.
Interest in human embryonic stem cells (hESCs) has grown steadily since the report of the first hESC
line in 1998. hESCs are attractive because of their potential as cell therapy, either directly replacing
cells or by using them as vehicles for gene therapy (Muller et al. 2006). But the cells themselves are
intrinsically interesting, because of their unique qualities of pluripotence and self-renewal, and these
qualities have led to a resurgence of interest in fundamental cell biology. hESC are the perfect tools
to study events that occur during human neurogenesis, both to understand normal development and
to identify what goes wrong during neurological disease. The versatility of hESC means that from the
same population one can generate multiple cell types that can then be used to dissect complex cellcell
interactions. For example, by differentiating hES cells into motor neurons, skeletal muscle cells,
and astroglia, one can do mix-and-match experiments to identify the vital components of degeneration
in ALS. By generating human/mouse chimeric brains using transplanted human neural stem cells or
neuronal precursors derived from hESC, it will be possible to ask how human neurons react to the
amyloid plaques that develop in transgenic models of Alzheimer's disease. Additionally, hESCs will
eventually be used for transplantation therapies in regenerative medicine. This Core facility proposes
to use only approved Presidential ES cell lines. The funds requested are particularly important because
Prop 71 which was to fund stem cell work in California has not become a reality, and it is currently
not clear if these funds will become available in the future. In addition to hESCs, this core will
allow neuroscientists on the La Jolla Torrey Pines Mesa access to methods regarding the use of murine
(m)ES cells. Additionally, the Stem Cell Core has expertise with neural progenitor cells (NPCs)
derived both from hES and mES cells. Moreover, NPCs from fetal human and mouse brains (obtained
by workers at BIMR and UCSD), and adult rodent NPCs (from the laboratory of Fred Gage at
The Salk Institute) will be available through this Stem Cell Core. The origins of all of these cells and
cell lines have received both Institutional approval and Presidential approval, where necessary for
hESC lines.
The purpose of the Stem Cell Core will be to provide training and fundamental analysis tools for stem
cell research throughout the La Jolla Torrey Pines Mesa. Currently, while there is an NIH-sponsored
Stem Cell Center at the Burnham Institute for Medical Research (BIMR), it is aimed at specific projects
and is insufficient to provide support for local neuroscientists who would like to use it. With this
grant, we propose to take advantage of the BIMR's experienced Stem Cell Center faculty and staff
and expand the capacity of the core laboratory to make the facilities available to all neuroscientists in
the La Jolla Torrey Pines Mesa area (UCSD, Salk, BIMR and TSRI). The Stem Cell Core will be directed
by Dr. Alexey Terskikh (BIMR, who trained with Prof. Irving Weismann, a well-known stem cell
expert at Stanford. Co-directors of the facility will be stem cell experts Drs. Evan Snyder and Jeanne
Loring (at BIMR), and Fred (Rusty) Gage and Juan Carlos Belmonte at The Salk Institute.
The overall objective of the Stem Cell core is to lower the barrier for neuroscientists to involve stem
cells in their research projects, by providing training and expert advice from experienced stem cell biologists.
This will improve communication among scientists in a variety of neuroscience subspecialties
to foster interdisciplinary collaborations and novel approaches. By sharing common techniques and
accumulated knowledge about the fundamental biology of human ES cells and somatic (adult) stem
cells, there will be a considerable savings in time, effort, and cost. The Stem Cell Core will play an important
role in ensuring that the users are kept up to date with the standardization of hESC methods
called for by the international stem cell scientific community (Andrews et al. 2005; Loring 2005).
The principal focus of this core is to provide stem cell-specific technologies that will lead to new insights
in neuroscience and aid in development of clinical applications for stem cells. For example,
correlation of the characteristics of stem cells in culture and their behavior after transplantation will
help in decisions about which cells to use and what quality control measures will be necessary for
clinical use. Core support will include culturing of ES and other stem cells, karyotyping, SNP genotyping,
microarray analysis, immunohistochemistry for stem cell and differentiation markers, assays for
pluripotence and differentiation, and access to BIMR's extensive databases of stem cell information.
In addition, the stem cell core faculty will offer advice for experimental design, data analysis, interpretation
of results, and assistance with manuscripts and grant applications. Stem cell core faculty will
also serve as mentors for postdocs and young faculty members, to help them publish and obtain grant
support.
干细胞核心
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STUART A LIPTON其他文献
STUART A LIPTON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STUART A LIPTON', 18)}}的其他基金
Crosstalk between innate-immunity human microglia and adaptive-immunity Tregs in Alzheimer's disease
阿尔茨海默病中先天免疫人类小胶质细胞和适应性免疫 Tregs 之间的串扰
- 批准号:
10686979 - 财政年份:2022
- 资助金额:
$ 6.36万 - 项目类别:
Crosstalk between innate-immunity human microglia and adaptive-immunity Tregs in Alzheimer's disease
阿尔茨海默病中先天免疫人类小胶质细胞和适应性免疫 Tregs 之间的串扰
- 批准号:
10515987 - 财政年份:2022
- 资助金额:
$ 6.36万 - 项目类别:
Pro-Electrophilic Drugs PEDs for Alzheimer's Disease
用于治疗阿尔茨海默病的亲电药物 PED
- 批准号:
10230417 - 财政年份:2020
- 资助金额:
$ 6.36万 - 项目类别:
Pro-Electrophilic Drugs PEDs for Alzheimer's Disease
用于治疗阿尔茨海默病的亲电药物 PED
- 批准号:
10256731 - 财政年份:2020
- 资助金额:
$ 6.36万 - 项目类别:
S-Nitrosylation-Induced Posttranslational Modification and Aberrant Cell Signaling in Sporadic Alzheimer's Disease
散发性阿尔茨海默病中 S-亚硝基化诱导的翻译后修饰和异常细胞信号转导
- 批准号:
9919542 - 财政年份:2017
- 资助金额:
$ 6.36万 - 项目类别:
S-Nitrosylation-Induced Posttranslational Modification and Aberrant Cell Signaling in Sporadic Alzheimer's Disease
散发性阿尔茨海默病中 S-亚硝基化诱导的翻译后修饰和异常细胞信号转导
- 批准号:
9355868 - 财政年份:2017
- 资助金额:
$ 6.36万 - 项目类别:
Novel Proteomics Approach to HIV-Associated Neurocognitive Disorder & Drug Abuse
治疗 HIV 相关神经认知障碍的蛋白质组学新方法
- 批准号:
9884749 - 财政年份:2016
- 资助金额:
$ 6.36万 - 项目类别:
相似海外基金
The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
- 批准号:
EP/Z000920/1 - 财政年份:2025
- 资助金额:
$ 6.36万 - 项目类别:
Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
- 批准号:
FT230100276 - 财政年份:2024
- 资助金额:
$ 6.36万 - 项目类别:
ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
- 批准号:
MR/X024261/1 - 财政年份:2024
- 资助金额:
$ 6.36万 - 项目类别:
Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
- 批准号:
DE240100388 - 财政年份:2024
- 资助金额:
$ 6.36万 - 项目类别:
Discovery Early Career Researcher Award
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
- 批准号:
2232190 - 财政年份:2023
- 资助金额:
$ 6.36万 - 项目类别:
Continuing Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
- 批准号:
2337595 - 财政年份:2023
- 资助金额:
$ 6.36万 - 项目类别:
Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
- 批准号:
23K17514 - 财政年份:2023
- 资助金额:
$ 6.36万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Analysis of thermoregulatory mechanisms by the CNS using model animals of female-dominant infectious hypothermia
使用雌性传染性低体温模型动物分析中枢神经系统的体温调节机制
- 批准号:
23KK0126 - 财政年份:2023
- 资助金额:
$ 6.36万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
- 批准号:
2842926 - 财政年份:2023
- 资助金额:
$ 6.36万 - 项目类别:
Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
- 批准号:
NC/X001644/1 - 财政年份:2023
- 资助金额:
$ 6.36万 - 项目类别:
Training Grant














{{item.name}}会员




